宏源药业 (301246.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(宏源药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 426,063,885.00496,167,047.85561,081,337.33493,723,786.01503,909,819.72450,158,620.87451,160,829.25
 营业收入(元) 426,063,885.00496,167,047.85561,081,337.33493,723,786.01503,909,819.72450,158,620.87451,160,829.25
二、营业总成本(元) 393,251,587.27510,203,945.26526,165,069.09493,078,534.24435,832,954.98391,257,451.37343,284,358.64
 营业成本(元) 359,024,437.28456,603,904.94478,586,599.69446,061,071.65406,762,504.38351,706,867.37308,555,420.35
 研发费用(元) 15,176,270.8719,442,943.5422,801,831.9116,140,052.2210,431,275.4816,113,378.679,811,654.03
 营业税金及附加(元) 2,347,202.485,462,542.113,009,730.273,190,425.251,684,464.202,521,935.783,236,146.25
 销售费用(元) 8,475,283.669,993,796.409,833,561.0211,295,590.516,567,541.4110,449,330.587,687,033.82
 管理费用(元) 9,886,104.4319,847,058.2112,795,369.5419,719,394.328,444,508.2917,053,524.7612,886,499.64
 财务费用(元) -1,657,711.45-1,146,299.94-862,023.34-3,327,999.711,942,661.22-6,587,585.791,107,604.55
  其中:利息费用(元) 2,557,508.004,198,663.023,901,507.644,464,105.20832,736.63-573,280.36
  其中:利息收入(元) 2,584,762.406,489,286.014,924,851.214,272,834.821,364,234.85-189,140.21
 资产减值损失(元) -4,715,838.50-15,973,900.26---10,406,058.98-636,772.69-1,457,917.93
 信用减值损失(元) -135,590.14825,008.33-439,342.50-7,178,264.572,281,144.39-2,560,966.85-1,250,327.50
三、其他经营收益
 加:公允价值变动收益(元) 3,996,997.27-15,143,080.616,847,324.36----
 加:投资收益(元) -849,561.0227,201,018.84-1,295,671.16-6,087,912.98-397,692.0957,299,982.8285,756,533.10
  其中:对联营企业和合营企业的投资收益(元) -6,749,666.382,355,191.14-3,507,990.83-6,105,693.37-883,791.62-85,756,533.10
 资产处置收益(元) 75,199.82139,844.6870,914.68136,976.65220,801.68--
 其他收益(元) 3,982,300.65535,639.884,400,708.893,049,058.2116,100,507.9516,497,139.821,632,083.68
四、营业利润(元) 35,165,805.81-16,452,366.5544,500,202.511,721,100.9575,875,567.69143,264,158.21192,556,841.96
 加:营业外收入(元) 54,045.7831,100.0086,372.1911,801.7226,900.0018,200.00124,817.00
 减:营业外支出(元) 141,200.014,922.545,695,235.381,404,440.97138,016.062,087,758.83378,259.04
五、利润总额(元) 35,078,651.58-16,426,189.0938,891,339.32328,461.7075,764,451.63141,194,599.38192,303,399.92
 减:所得税费用(元) 3,879,589.96-7,294,636.117,614,599.9849,387.8811,020,085.5715,455,181.0715,505,859.67
六、净利润(元) 31,199,061.62-9,131,552.9831,276,739.34279,073.8264,744,366.06125,739,418.31176,797,540.25
(一)按经营持续性分类
  持续经营净利润(元) 31,199,061.62-9,131,552.9831,276,739.34279,073.8264,744,366.06-176,797,540.25
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 31,199,061.62-9,131,552.9831,276,739.34279,073.8264,744,366.06125,739,418.31176,797,540.25
 扣除非经常性损益后的净利润(元) 19,063,757.02-15,200,956.1924,128,247.66-10,951,459.4150,516,352.97106,116,100.00175,591,100.00
七、每股收益
 一、基本每股收益(元) 0.08-0.030.08-0.010.180.360.50
 二、稀释每股收益(元) 0.08-0.030.08-0.010.180.360.50
九、综合收益总额(元) 31,199,061.62-9,131,552.9831,276,739.34279,073.8264,744,366.06125,739,418.31176,797,540.25
 归属于母公司所有者的综合收益总额(元) 31,199,061.62-9,131,552.9831,276,739.34279,073.8264,744,366.06125,739,418.31176,797,540.25
公告日期 2024-04-232024-04-232023-10-282023-08-312023-04-282022-08-262023-04-28
审计意见(境内) 标准无保留意见标准无保留意见

前瞻产业研究院